Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults : how do they differ from those in seasonal influenza?
BACKGROUND: It is unclear whether pandemic 2009 influenza A (pH1N1) infection caused more significant disease among hospitalized adults than seasonal influenza.
METHODS: A prospective, observational study was conducted in adults hospitalized with polymerase chain reaction-confirmed pH1N1 infection in 2 acute-care general hospitals from June 2009 to May 2010 (n = 382). Complications and outcomes were described and compared with those in a seasonal influenza cohort (2007-2008, same hospitals; n = 754).
RESULTS: Hospitalized patients with pH1N1 influenza were younger than those with seasonal influenza (mean age ± standard deviation, 47 ± 20 vs 70 ± 19 years) and fewer had comorbid conditions (48% vs 64%). The rate of positive immunofluorescence assay results was low (54% vs 84%), and antiviral use was frequent (96% vs 52%). Most patients in both cohorts developed complicated illnesses (67.8% vs 77.1%), but patients with pH1N1 influenza had higher rates of extrapulmonary complications (23% vs 16%; P = .004) and intensive care unit admission and/or death (patient age <35 years, 2.3% vs 0%; 35-65 years, 12.4% vs 3.2%; >65 years, 13.5% vs 8.5%; adjusted odds ratio [OR] 2.13; 95% confidence interval [CI], 1.25-3.62; P = .005). Patients who received antiviral treatment within 96 h after onset had better survival (log-rank test, P < .001). However, without timely treatment, the mortality risk was higher with pH1N1 infection (9.0% vs 5.8% for seasonal influenza; adjusted OR, 6.85; 95% CI, 1.64-28.65; P = .008]. Bacterial superinfection worsened outcomes.
CONCLUSIONS: Adults hospitalized for pH1N1 influenza had significant complications and mortality despite being younger than patients with seasonal influenza. Antiviral treatment within 96 h may improve survival.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:203 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 203(2011), 12 vom: 15. Juni, Seite 1739-47 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Nelson [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antiviral Agents |
---|
Anmerkungen: |
Date Completed 28.07.2011 Date Revised 21.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jir187 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM208564098 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM208564098 | ||
003 | DE-627 | ||
005 | 20231224004222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jir187 |2 doi | |
028 | 5 | 2 | |a pubmed24n0695.xml |
035 | |a (DE-627)NLM208564098 | ||
035 | |a (NLM)21606532 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lee, Nelson |e verfasserin |4 aut | |
245 | 1 | 0 | |a Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults |b how do they differ from those in seasonal influenza? |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.07.2011 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: It is unclear whether pandemic 2009 influenza A (pH1N1) infection caused more significant disease among hospitalized adults than seasonal influenza | ||
520 | |a METHODS: A prospective, observational study was conducted in adults hospitalized with polymerase chain reaction-confirmed pH1N1 infection in 2 acute-care general hospitals from June 2009 to May 2010 (n = 382). Complications and outcomes were described and compared with those in a seasonal influenza cohort (2007-2008, same hospitals; n = 754) | ||
520 | |a RESULTS: Hospitalized patients with pH1N1 influenza were younger than those with seasonal influenza (mean age ± standard deviation, 47 ± 20 vs 70 ± 19 years) and fewer had comorbid conditions (48% vs 64%). The rate of positive immunofluorescence assay results was low (54% vs 84%), and antiviral use was frequent (96% vs 52%). Most patients in both cohorts developed complicated illnesses (67.8% vs 77.1%), but patients with pH1N1 influenza had higher rates of extrapulmonary complications (23% vs 16%; P = .004) and intensive care unit admission and/or death (patient age <35 years, 2.3% vs 0%; 35-65 years, 12.4% vs 3.2%; >65 years, 13.5% vs 8.5%; adjusted odds ratio [OR] 2.13; 95% confidence interval [CI], 1.25-3.62; P = .005). Patients who received antiviral treatment within 96 h after onset had better survival (log-rank test, P < .001). However, without timely treatment, the mortality risk was higher with pH1N1 infection (9.0% vs 5.8% for seasonal influenza; adjusted OR, 6.85; 95% CI, 1.64-28.65; P = .008]. Bacterial superinfection worsened outcomes | ||
520 | |a CONCLUSIONS: Adults hospitalized for pH1N1 influenza had significant complications and mortality despite being younger than patients with seasonal influenza. Antiviral treatment within 96 h may improve survival | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antiviral Agents |2 NLM | |
700 | 1 | |a Chan, Paul K S |e verfasserin |4 aut | |
700 | 1 | |a Lui, Grace C Y |e verfasserin |4 aut | |
700 | 1 | |a Wong, Bonnie C K |e verfasserin |4 aut | |
700 | 1 | |a Sin, Winnie W Y |e verfasserin |4 aut | |
700 | 1 | |a Choi, Kin-Wing |e verfasserin |4 aut | |
700 | 1 | |a Wong, Rity Y K |e verfasserin |4 aut | |
700 | 1 | |a Lee, Elaine L Y |e verfasserin |4 aut | |
700 | 1 | |a Yeung, Apple C M |e verfasserin |4 aut | |
700 | 1 | |a Ngai, Karry L K |e verfasserin |4 aut | |
700 | 1 | |a Chan, Martin C W |e verfasserin |4 aut | |
700 | 1 | |a Lai, Raymond W M |e verfasserin |4 aut | |
700 | 1 | |a Yu, Alex W Y |e verfasserin |4 aut | |
700 | 1 | |a Hui, David S C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 203(2011), 12 vom: 15. Juni, Seite 1739-47 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:203 |g year:2011 |g number:12 |g day:15 |g month:06 |g pages:1739-47 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jir187 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 203 |j 2011 |e 12 |b 15 |c 06 |h 1739-47 |